1/8/2013
Beginning February 18, 2013 two erythropoiesis-stimulating agents (ESA) will be added to the list of drugs that require precertification for individuals with a Cigna PHS+ medical management model:
- J0881 - Darbepoetin (Aranesp)
- J0885 - Epoetin (Epogen, Procrit)
The two ESA drugs are prescribed for non-end stage renal disease conditions and already require precertification under the Cigna pharmacy benefits.